Artículos por temáticas

Computational modelling of Parkinson's disease: A multiscale approach with deep brain stimulation and stochastic noise

Herrera A, Shaheen H.

ArXiv [Preprint]. 2025 Sep 16:arXiv:2509.08179v2.

Reviving mitochondria to restore the mind: stem cell-based bioenergetic rescue in Parkinson's disease

Shidhaye S, Chaudhary AA, Gajghate M, Singanwad P, Umekar M, Raut N, Rudayni HA, Trivedi R.

Neurodegener Dis Manag. 2025 Sep 19:1-11. doi: 10.1080/17582024.2025.2562741. Online ahead of print.

Recent Insights in Multi-Target Drugs in Pharmacology and Medicinal Chemistry

Cemali SH, Poyraz S, Belveren S, Taş S, Tamer MA, Döndaş NY, Döndaş HA, Sansano JM.

ChemMedChem. 2025 Sep 1:e202500447. doi: 10.1002/cmdc.202500447. Online ahead of print.

Current Evidence on the Involvement of RAGE-Diaph1 Signaling in the Pathology and Treatment of Neurodegenerative Diseases-An Overview

Juranek JK, Kordas B, Podlasz P, Bossowska A, Banach M.

Pathophysiology. 2025 Aug 29;32(3):43. doi: 10.3390/pathophysiology32030043.

Bidirectional Relationship between the BDNF Gene and miRNA: Implications for PD Pathogenesis

Elangovan A, Iyer M, Reddy DH, Wander A, Kinoshita M, Krishnan J, Vellingiri B.

ACS Chem Neurosci. 2025 Sep 17;16(18):3411-3424. doi: 10.1021/acschemneuro.5c00173. Epub 2025 Sep 3.

Wearable devices in neurological disorders: a narrative review of status quo and perspectives

Cai H, Hu J, Zhao C, Lin J.

Ann Transl Med. 2025 Aug 31;13(4):46. doi: 10.21037/atm-25-46. Epub 2025 Aug 26.

Protocol considerations for single and paired pulse transcranial magnetic stimulation in Parkinson's disease

Sivaramakrishnan A, Jordan HT, Stinear CM.

Neurophysiol Clin. 2025 Sep;55(5):103097. doi: 10.1016/j.neucli.2025.103097. Epub 2025 Aug 21.

Gut microbial shifts toward inflammation in Parkinson's disease: Insights from pilot shotgun metagenomics Egyptian cohort

Shalash A, Ezzeldin S, Hashish S, Salah Y, Dawood NL, Moustafa A, Salama M.

J Parkinsons Dis. 2025 Sep 17:1877718X251370156. doi: 10.1177/1877718X251370156. Online ahead of print.

Protein palmitoylation: an emerging regulator of inflammatory signaling and diseases

Chen R, Tang X, Wang Y, Wang B, Mao F.

Front Immunol. 2025 Sep 1;16:1652741. doi: 10.3389/fimmu.2025.1652741. eCollection 2025.

Enhancing healthspan with Ashwagandha (Withania somnifera): a comprehensive review of its multifaceted geroprotective benefits

Vittal M, Vinciguerra M.

Biogerontology. 2025 Sep 8;26(5):179. doi: 10.1007/s10522-025-10320-0.

The LRRK2 p.A419V variant associates with risk of Parkinson's disease in the East Asian population and an evaluation on age of onset

Lim KS, Periñan MT, Chew EGY, Lee PS, Akçimen F, Lim JL, Koretsky MJ, Funayama M, Yoshino H, Hattori N, Kaiyrzhanov R, Houlden H, Isayan M, Tay YW, Toh TS, Lit LC, Khairul Anuar AN, Ding HX, Screven L

medRxiv [Preprint]. 2025 Sep 2:2025.08.28.25333987. doi: 10.1101/2025.08.28.25333987.

Pharmacological strategies for managing dementia with Lewy bodies: an expert review of symptom-targeted care

Atewogboye O, Taylor JP, Harrison JR.

Expert Rev Clin Pharmacol. 2025 Sep 19:1-9. doi: 10.1080/17512433.2025.2562151. Online ahead of print.

Improving the Study of Impulse Control Disorders in CSAI-Treated Parkinson's Disease: Methodological and Interdisciplinary Directions

Wang Y, He Y, Cai H.

Mov Disord Clin Pract. 2025 Sep 2. doi: 10.1002/mdc3.70316. Online ahead of print.

Canonical and alternate mechanisms that regulate ubiquitylation by the E3 ligase parkin

Basilone NT, Pimenta VM, Shaw GS.

Biochem Soc Trans. 2025 Aug 29;53(4):1053-1065. doi: 10.1042/BST20253050.

Anti-neurodegenerative treatment in Alzheimer's disease: Multifaceted mechanisms of action of berberine

Song D, Zhang C.

Int J Clin Pharmacol Ther. 2025 Sep;63(9):432-438. doi: 10.5414/CP204725.